Trial
NCT05483023
18-fluorofuranylnorprogesterone (FFNP) PET/MRI as a Potential Biomarker of Response to Progesterone Therapy
Phase IIWITHDRAWNOTHER/UNKNOWNConfidence: LOW
Sponsor
UNC Lineberger Comprehensive Cancer Center
Collaborators
Radiological Society of North America
Condition
Complex Atypical Hyperplasia
Intervention
18F-fluorofuranylnorprogesterone PET / MRI
Why stopped
Drug cannot be produced and scanner down.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-10-14